Ticagrelor With Aspirin or Alone in High-Risk Patients After Coronary Intervention (TWILIGHT) - Adventist HealthCare

Clinical Trial Details

TWILIGHT

Ticagrelor With Aspirin or Alone in High-Risk Patients After Coronary Intervention (TWILIGHT)

Purpose/Objective

Request Additional Trial Information
Full Trial Details: ClinicalTrials.gov

Condition: Coronary Artery Disease
Study Type: Interventional
Phase: Phase IV
Study Start Date: 05/16/2016
Study Completion Date: TBD

This study is to compare the use of ticagrelor alone versus ticagrelor and aspirin together. Both ticagrelor and aspirin stop platelets from sticking together and forming a blood clot that could block blood flow to the heart. This study will look to determine the effectiveness and safety of ticagrelor alone, compared to ticagrelor plus aspirin in reducing clinically relevant bleeding and in reducing ischemic adverse events among high-risk patients who have had a percutaneous intervention with at least one drug-eluting stent.

NCT Number
NCT02270242
Principal Investigator(s)
Thomas Wang, MD
Sponsor(s)
Icahn School of Medicine at Mount Sinai
Participant Eligibility
  • Age: 18 - No Maximum
  • Gender: Male, Female

Location

  • Adventist HealthCare Washington Adventist Hospital
    7600 Carroll Avenue
    Takoma Park, MD 20912
    Main: 301-891-7600

Find a Doctor

Find an Adventist HealthCare affiliated doctor by calling our FREE physician referral service at 800-642-0101 or by searching our online physician directory.

View Doctors

Set Your Location

Setting your location helps us to show you nearby providers and locations based on your healthcare needs.